Bellevue Life Sciences Acquisition Corp. (BLAC) Financial Statements
$3.01NASDAQ: BLACMarket Cap $6.98M
Bellevue Life Sciences Acquisition Corp. most recently reported annual revenue of $3.0M, a net loss of $29.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Bellevue Life Sciences Acquisition Corp.: net profit was positive in 0 of 6 reported years; the most recent year shows a net loss of $29.0M.
Income Statement — 6 Years (USD millions)
Metric
2020
2021
2022
2023
2024
2025
Revenue
$0
$0
$0
$0
$0
$3.0M
Operating Expenses
$0
$0
$0
$2.0M
$4.0M
$21.0M
Operating Profit
$0
$0
$0
$-2.0M
$-4.0M
$-18.0M
Operating Margin
0.0%
0.0%
0.0%
0.0%
0.0%
-631.0%
Other Income
$0
$0
$0
$3.0M
$1.0M
$-11.0M
Interest
$0
$0
$0
$0
$0
$0
Depreciation
$0
$0
$0
$3.0M
$0
$0
Profit Before Tax
$0
$0
$0
$1.0M
$-2.0M
$-29.0M
Tax
$0
$0
$0
$57.3M
$14.0M
$0
Net Profit
$0
$0
$0
$0
$-2.0M
$-29.0M
EPS
$0.00
$0.00
$0.00
$0.07
$-0.54
$0.00
Dividend Payout
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Results — Last 12 Quarters (USD millions)
8 duplicate period labels in the source data were collapsed.
Metric
Jun '23
Sep '23
Dec '23
Mar '24
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Revenue
$0
$0
$0
$0
$0
$0
$0
$1.0M
$1.0M
$1.0M
$0
$0
Operating Expenses
$0
$0
$1.0M
$0
$0
$0
$2.0M
$4.0M
$6.0M
$4.0M
$7.0M
$4.0M
Operating Profit
$0
$0
$-1.0M
$0
$0
$0
$-2.0M
$-3.0M
$-5.0M
$-4.0M
$-6.0M
$-4.0M
Operating Margin
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
-383.3%
-460.5%
-605.9%
-1674.8%
-757.6%
Interest
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
$0
Profit Before Tax
$1.0M
$0
$0
$0
$0
$0
$-2.0M
$-11.0M
$-5.0M
$-4.0M
$-8.0M
$-4.0M
Tax
$43.1M
$62.4M
$228.9M
$301.1M
$-869.2M
$-24.9M
$26.6M
$0
$0
$28.8M
$-16.6M
$11.5M
Net Profit
$0
$0
$0
$0
$0
$0
$-2.0M
$-11.0M
$-5.0M
$-3.0M
$20.0M
$-3.0M
EPS
$0.03
$0.01
$-0.01
$-0.01
$-0.02
$-0.06
$-0.45
$-2.54
$-1.17
$-0.71
$4.42
$-0.09
Over the 6 years reported for Bellevue Life Sciences Acquisition Corp., cash stood at $2.0M in the latest year, shareholders' equity was $0.
Balance Sheet — 6 Years (USD millions)
Metric
2020
2021
2022
2023
2024
2025
Total Assets
$0
$1.0M
$1.0M
$37.0M
$2.0M
$2.0M
Current Assets
$0
$0
$0
$0
$0
$2.0M
Cash
$0
$0
$0
$0
$0
$2.0M
Inventory
$0
$0
$0
$0
$0
$0
Receivables
$0
$0
$0
$0
$0
$0
Fixed Assets
$0
$0
$0
$0
$0
$0
Capital Work in Progress
$0
$0
$0
$0
$0
$0
Investments
$0
$0
$0
$37.0M
$2.0M
$0
Other Assets
$0
$0
$0
$0
$0
$0
Total Liabilities
$0
$1.0M
$1.0M
$4.0M
$9.0M
$0
Current Liabilities
$0
$1.0M
$1.0M
$2.0M
$7.0M
$0
Borrowings
$0
$0
$1.0M
$0
$2.0M
$0
Other Liabilities
$0
$0
$0
$4.0M
$7.0M
$0
Equity
$0
$0
$0
$36.0M
$2.0M
$0
Reserves
$0
$0
$0
$33.0M
$-6.0M
$0
For Bellevue Life Sciences Acquisition Corp., operating cash flow was positive in 0 of 6 reported years; free cash flow in the latest year was $0; free cash flow was positive in 0 of 6 years.
What is Bellevue Life Sciences Acquisition Corp.'s annual revenue?
Bellevue Life Sciences Acquisition Corp. (BLAC) reported annual revenue of $3.0M in its most recent fiscal year.
What is Bellevue Life Sciences Acquisition Corp.'s net profit?
Bellevue Life Sciences Acquisition Corp. (BLAC) reported a net loss of $29.0M in its most recent fiscal year.
What is BLAC EV/EBITDA?
Bellevue Life Sciences Acquisition Corp.'s enterprise value to EBITDA (EV/EBITDA) ratio is -0.51. A negative value means EBITDA was negative over the period, so the ratio is not a meaningful valuation measure.